Managing Renal Masses
Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence, a new evidence-based publication from AHRQ's Effective Health Care Program, can help clinicians make informed decisions about managing renal masses and localized renal cell carcinoma—a kidney cancer that affects approximately 65,000 new patients each year.
The publication summarizes findings of a systematic review that evaluated the benefits and adverse effects of screening and treating patients with a renal mass that potentially could be localized renal cell carcinoma.
Evidence indicates there is no clear method for predicting kidney cancer during diagnosis of renal masses. Tumor size and male sex, however, are highly associated with malignancy. In addition, evidence does not support one management strategy over another; treatment decisionmaking may be affected by patient factors such as comorbidities, life expectancy, tumor characteristics (e.g., size and location), and patient values and preferences.
Page originally created July 2017